Comparing two treatments for rapidly spreading vitiligo in children
Treatments studied
Part of Skin clinical trials.
This trial compares two medicines—oral tacrolimus and dexamethasone micro-pulse therapy—in children aged 4 to 12 whose vitiligo is spreading quickly. The goal is to see which treatment works better to stop the spread and help color return to the skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 4 and 12 years old.
- Their vitiligo is the non-segmental type (patches on both sides of the body) and has been spreading quickly in the last 6 weeks.
- The vitiligo covers between 1% and 50% of their body surface.
- They have not used strong medicines that affect the immune system (like oral steroids) in the last 4 weeks.
- They do not have serious liver or kidney problems, infections, or other major health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cream called ruxolitinib to see if it can safely and effectively restore skin color in children with vitiligo. It may help reduce white patches on the skin.
This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.
This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.
This trial tests whether taking short courses of steroid pills alongside a skin cell transplant procedure helps treat stubborn vitiligo patches on the elbows and knees that have not improved with standard treatments.
This study compares two treatments for vitiligo: narrowband UVB light therapy combined with either tacrolimus ointment or calcipotriol ointment. It aims to see which combination works better and is safer for people with stable, limited vitiligo.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.